Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In an intervention study in healthy volunteers, the use of metformin resulted in a change in >80 bacterial species compared with a control group receiving a placebo. Metformin promotes the growth of short-chain fatty acid producers in the gut, which contribute to its therapeutic benefits in improving insulin resistance and glucose homeostasis. The authors transplanted fecal samples from metformin-treated or placebo-treated donors into [germ-free mice](br…